Our study reveals a previously unrecognized pathway and explains a new mechanism of YAP1 and EMT in NSCLC; these results thus suggest several novel therapeutic targets, including YAP1 and Slug. This evidence concerns the gene SNAI2 and non-small cell lung carcinoma.